Joshua Yang

Biotechnology Entrepreneur

 · Co-founder and CEO of Glyphic Biotechnologies, a Seed-stage biotech startup developing next-generation protein sequencing.
 · Co-founder of Nephrosant, a Series A-stage diagnostics biotech startup commercializing non-invasive kidney disease diagnostics.

 · MBA @ Stanford Graduate School of Business
 · MD-PhD candidate @ Johns Hopkins University School of Medicine and Department of Biomedical Engineering
 · M.Eng. in Translational Medicine @ UC San Francisco and UC Berkeley
 · B.S. in Bioengineering: Biotechnology and B.S. in General Biology @ UC San Diego

 · Forbes 30 Under 30 Healthcare
 · Biocom California's Life Science Catalyst Award

 · Email:
 · Professional Profile: LinkedIn
 · Research Publications: Google Scholar
 · CV: PDF
· Twitter: @joshuayoungyang

Recent News

October 2021
 · I was selected as one of Biocom California's Life Science Catalyst Award winners, recognizing those who are making their mark on the California life science industry before reaching their 40th birthday

June 2021
 · I graduated from the Stanford Graduate School of Business as the Henry Ford II Scholar (Valedictorian) and as an Arjay Miller Scholar (Top 10%).

April 2021
 · I was listed on the 2021 Best & Brightest MBAs list by Poets & Quants.

December 2020
 · I was named as a Forbes 30 Under 30 on their 2021 Healthcare list.
 · I was awarded a grant by the Roddenbury Foundation from their Catalyst Fund to validate Cerviscope's cervical cancer screening technology.

June 2020
 · My team and I won 1st place at the Merck Innovation Cup 2020 for our proposal for a novel drug discovery platform, having been selected out of over 2,000 applicants.
 · My perspective piece titled, A Pandemic of Loneliness, was published in Doximity's Op-Med.
 · My article on how to find fellowships and scholarships for graduate school was published by Sallie Mae on their Within Reach blog.

April 2020
 · Our global health project Cerviscope won 2nd place at the Johns Hopkins Healthcare Design Competition and was a finalist for the Bisciotti Student Entrepreneurship Award

March 2020
 · My first-author publication on Nephrosant's QSant Assay was published in Science Translational Medicine
 · My startup Nephrosant and I were featured in GenomeWeb about the upcoming launch of our QSant assay.
 · I was featured in Poets & Quants 'Meet Stanford GSB's MBA Class of 2021'